ONSHORE TRADING CO LTD

Company number 13937929 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ONSHORE TRADING CO LTD - Analysis Report

Company Number: 13937929

Analysis Date: 2025-07-19 12:24 UTC

Financial Health Assessment: ONSHORE TRADING CO LTD


1. Financial Health Score: C

Explanation:
ONSHORE TRADING CO LTD demonstrates some strengths such as positive net assets and investment in fixed assets, but also shows clear symptoms of financial distress, especially a severe working capital deficit in the latest year. The overall financial health is moderate with risks that require active management to avoid worsening liquidity problems.


2. Key Vital Signs

Metric 2024 (£) 2023 (£) Interpretation
Fixed Assets 478,142 3,917 Significant increase due to acquisition of land/buildings; a long-term investment "organ transplant"
Current Assets 8,865 26,206 Shrunk sharply, signaling a reduced "energy reserve" (liquid assets)
Cash at Bank 3,865 26,206 Cash reserves have depleted substantially, indicating potential liquidity stress
Current Liabilities 438,914 6,050 Huge rise mainly due to "other creditors" (£409k), alarming "symptom of distress"
Net Current Assets (Working Capital) (430,049) 20,156 Negative working capital shows liquidity pressure; company cannot cover short-term debts
Net Assets (Equity) 48,093 24,073 Positive net assets indicate some "core strength" and shareholder value preservation
Share Capital 300 300 No change; minimal equity base

3. Diagnosis

  • Liquidity Crisis: The most critical symptom is the severe negative net current assets (£-430k) in 2024, a sharp deterioration from a positive £20k in 2023. This means current liabilities far exceed current assets, threatening the company's ability to meet short-term obligations. The spike in "other creditors" (£409k) is the main driver and could be loans, deferred payments, or accruals that require urgent attention.

  • Asset Investment: The company has made a large investment in fixed assets (land and buildings) valued at £438k, which can be viewed as a strategic "organ transplant" to support future growth. However, these assets are not liquid and cannot be quickly converted to cash to relieve immediate cash flow issues.

  • Cash Flow Weakness: Cash reserves have dropped from £26k to under £4k, reducing the company's "circulatory system" for operations.

  • Equity Growth: Despite liquidity stress, net assets have doubled from £24k to £48k, due to retained earnings and asset revaluation/amortisation. This suggests the company is building some equity cushion but it is still small relative to liabilities.

  • Small Company Status & Exemption: The company qualifies as a small entity and has taken advantage of audit exemptions, which is typical but means less detailed external scrutiny.

  • Operating Scale: The company employs 2 people, indicating a micro/small scale operation, which adds pressure on cash flows when liabilities balloon.

Overall, the company shows signs of "acute liquidity distress" but still retains a "healthy heart" in terms of positive equity and strategic asset investments. The situation is serious but potentially recoverable with careful management.


4. Recommendations

  1. Urgent Liquidity Management:

    • Engage with creditors, especially those under "other creditors" to negotiate payment terms/extensions.
    • Explore short-term financing solutions (overdraft, invoice financing) to ease cash flow.
    • Tighten cash flow monitoring and forecasting.
  2. Working Capital Recovery:

    • Review inventory management to avoid stock obsolescence (currently £5k stock).
    • Accelerate debtor collections if applicable (though current assets are low).
    • Delay non-essential payments without damaging supplier relationships.
  3. Asset Utilization:

    • Evaluate if part of the fixed assets (land/buildings) can be leveraged (e.g., sale and leaseback) to generate cash.
    • Ensure depreciation and amortisation are appropriately reflected in future financial planning.
  4. Financial Reporting & Oversight:

    • Consider preparing more detailed management accounts and potentially audited accounts in future for greater transparency.
    • Directors should review financial strategy regularly and consider external financial advice.
  5. Growth & Profitability Focus:

    • Develop strategies to increase turnover and profitability to improve cash inflows.
    • Control overheads strictly to avoid further liquidity strain.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.